Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.

van Mulligen E, de Jong PHP, Kuijper TM, van der Ven M, Appels C, Bijkerk C, Harbers JB, de Man Y, Molenaar THE, Tchetverikov I, Goekoop-Ruiterman YPM, van Zeben J, Hazes JMW, Weel AEAM, Luime JJ.

Ann Rheum Dis. 2019 Jun;78(6):746-753. doi: 10.1136/annrheumdis-2018-214970. Epub 2019 Apr 6.

2.

Delirium after hip hemiarthroplasty for proximal femoral fractures in elderly patients: risk factors and clinical outcomes.

de Jong L, van Rijckevorsel VAJIM, Raats JW, Klem TMAL, Kuijper TM, Roukema GR.

Clin Interv Aging. 2019 Feb 26;14:427-435. doi: 10.2147/CIA.S189760. eCollection 2019.

3.

Validation of the Nottingham Hip Fracture Score (NHFS) to predict 30-day mortality in patients with an intracapsular hip fracture.

de Jong L, Mal Klem T, Kuijper TM, Roukema GR.

Orthop Traumatol Surg Res. 2019 May;105(3):485-489. doi: 10.1016/j.otsr.2019.02.004. Epub 2019 Mar 9.

PMID:
30862492
4.

Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study.

Walter MJM, Kuijper TM, Hazes JMW, Weel AE, Luime JJ.

Rheumatol Int. 2018 Sep;38(9):1643-1650. doi: 10.1007/s00296-018-4102-5. Epub 2018 Jul 16.

5.

ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.

Bondt A, Hafkenscheid L, Falck D, Kuijper TM, Rombouts Y, Hazes JMW, Wuhrer M, Dolhain RJEM.

Ann Rheum Dis. 2018 Aug;77(8):1130-1136. doi: 10.1136/annrheumdis-2018-212946. Epub 2018 Apr 3.

PMID:
29615411
6.

The minimally invasive anterolateral approach versus the traditional anterolateral approach (Watson-Jones) for hip hemiarthroplasty after a femoral neck fracture: an analysis of clinical outcomes.

de Jong L, Klem TMAL, Kuijper TM, Roukema GR.

Int Orthop. 2018 Aug;42(8):1943-1948. doi: 10.1007/s00264-017-3756-z. Epub 2018 Jan 6.

PMID:
29307031
7.

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases.

Engelhard EAN, Smit C, van Dijk PR, Kuijper TM, Wermeling PR, Weel AE, de Boer MR, Brinkman K, Geerlings SE, Nieuwkerk PT.

AIDS. 2018 Jan 2;32(1):103-112. doi: 10.1097/QAD.0000000000001672.

PMID:
29112062
8.

Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study.

Kuijper TM, Luime JJ, Xiong H, de Jong P, van der Lubbe P, van Zeben D, Tchetverikov I, Hazes J, Weel A.

Scand J Rheumatol. 2018 May;47(3):178-184. doi: 10.1080/03009742.2017.1349176. Epub 2017 Oct 2.

PMID:
28967272
9.

Factors affecting the rate of surgical site infection in patients after hemiarthroplasty of the hip following a fracture of the neck of the femur.

de Jong L, Klem TMAL, Kuijper TM, Roukema GR.

Bone Joint J. 2017 Aug;99-B(8):1088-1094. doi: 10.1302/0301-620X.99B8.BJJ-2016-1119.R1.

PMID:
28768787
10.

IgA N- and O-glycosylation profiling reveals no association with the pregnancy-related improvement in rheumatoid arthritis.

Bondt A, Nicolardi S, Jansen BC, Kuijper TM, Hazes JMW, van der Burgt YEM, Wuhrer M, Dolhain RJEM.

Arthritis Res Ther. 2017 Jul 5;19(1):160. doi: 10.1186/s13075-017-1367-0.

11.

Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice.

Kuijper TM, Buisman LR, Hazes JM, Weel AE.

J Rheumatol. 2017 Jul;44(7):965-967. doi: 10.3899/jrheum.170334. No abstract available.

PMID:
28668812
12.

Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.

Kuijper TM, Folmer R, Stolk EA, Hazes JMW, Luime JJ.

Arthritis Res Ther. 2017 Apr 26;19(1):78. doi: 10.1186/s13075-017-1287-z.

13.

No clear association between ultrasound remission and health status in rheumatoid arthritis patients in clinical remission.

van der Ven M, Kuijper TM, Gerards AH, Tchetverikov I, Weel AE, van Zeben J, Hazes JM, Luime JJ.

Rheumatology (Oxford). 2017 Aug 1;56(8):1276-1281. doi: 10.1093/rheumatology/kex080.

PMID:
28407127
14.

Fab glycosylation of immunoglobulin G does not associate with improvement of rheumatoid arthritis during pregnancy.

Bondt A, Wuhrer M, Kuijper TM, Hazes JM, Dolhain RJ.

Arthritis Res Ther. 2016 Nov 25;18(1):274.

15.

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.

Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE.

Ann Rheum Dis. 2016 Dec;75(12):2119-2123. doi: 10.1136/annrheumdis-2016-209272. Epub 2016 Jun 9.

PMID:
27283332
16.

Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.

Kuijper TM, Lamers-Karnebeek FB, Jacobs JW, Hazes JM, Luime JJ.

J Rheumatol. 2015 Nov;42(11):2012-22. doi: 10.3899/jrheum.141520. Epub 2015 Oct 1. Review.

PMID:
26428204
17.

Quality of life and health care use in patients with arthralgias without synovitis compared with patients diagnosed with early rheumatoid arthritis: data from an early arthritis cohort.

Kuijper TM, Luime JJ, Alves C, Barendregt PJ, van Zeben J, Bindels PJ, Hazes JM.

Arthritis Care Res (Hoboken). 2014 Mar;66(3):379-86. doi: 10.1002/acr.22126.

18.

LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment.

Kuijper TM, Ruigrok-Ritstier K, Verhoef-Post M, Piersma D, Bruysters MW, Berns EM, Themmen AP.

Mol Cell Endocrinol. 2009 Apr 10;302(1):58-64. doi: 10.1016/j.mce.2008.12.016. Epub 2009 Jan 20.

Supplemental Content

Loading ...
Support Center